Suvorexant: a promising, novel treatment for insomnia
Joyce K Lee-Iannotti,1 James M Parish2 1Division of Neurology, Sleep Disorders Center, Banner University Medical Center, Phoenix, AZ, USA; 2Division of Pulmonary Medicine, Center for Sleep Medicine, Mayo Clinic, Phoenix, AZ, USA Abstract: Suvorexant a novel, orexin receptor antagonist was recently...
Saved in:
| Main Authors: | Lee-Iannotti J, Parish J |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2016-02-01
|
| Series: | Neuropsychiatric Disease and Treatment |
| Subjects: | |
| Online Access: | https://www.dovepress.com/suvorexant-a-promising-novel-treatment-for-insomnia-peer-reviewed-fulltext-article-NDT |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Characteristics of psychiatric patients with nightmares after suvorexant administration: A retrospective study
by: Kazuya Yasuda, et al.
Published: (2025-03-01) -
Green stability-indicating RP-HPTLC approach for determining suvorexant in commercial tablet dosage forms
by: Prawez Alam, et al.
Published: (2025-02-01) -
Perception of Lemborexant Effectiveness as Assessed by the Patient Global Impression–Insomnia Questionnaire
by: Drake CL, et al.
Published: (2025-04-01) -
Efficacy and safety of lemborexant in subjects with insomnia disorder receiving medications for depression or anxiety symptoms
by: Andrew Krystal, et al.
Published: (2025-03-01) -
Targeting ADG of Developing Replacement Heifers Using Age and Body Weight
by: Phillip Lancaster, et al.
Published: (2014-09-01)